These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 34902452)

  • 1. Current insights on extracellular vesicle-mediated glioblastoma progression: Implications in drug resistance and epithelial-mesenchymal transition.
    Mukherjee S; Pillai PP
    Biochim Biophys Acta Gen Subj; 2022 Mar; 1866(3):130065. PubMed ID: 34902452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma.
    Simon T; Pinioti S; Schellenberger P; Rajeeve V; Wendler F; Cutillas PR; King A; Stebbing J; Giamas G
    Mol Cancer; 2018 Aug; 17(1):132. PubMed ID: 30165850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles Induce Mesenchymal Transition and Therapeutic Resistance in Glioblastomas through NF-κB/STAT3 Signaling.
    Schweiger MW; Li M; Giovanazzi A; Fleming RL; Tabet EI; Nakano I; Würdinger T; Chiocca EA; Tian T; Tannous BA
    Adv Biosyst; 2020 Dec; 4(12):e1900312. PubMed ID: 32519463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in Glioblastoma Tumor Microenvironment.
    Yekula A; Yekula A; Muralidharan K; Kang K; Carter BS; Balaj L
    Front Immunol; 2019; 10():3137. PubMed ID: 32038644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor progression and M2 microglial polarization by extracellular vesicle-mediated microRNA-124 in a 3D microfluidic glioblastoma microenvironment.
    Hong S; You JY; Paek K; Park J; Kang SJ; Han EH; Choi N; Chung S; Rhee WJ; Kim JA
    Theranostics; 2021; 11(19):9687-9704. PubMed ID: 34646393
    [No Abstract]   [Full Text] [Related]  

  • 6. Extracellular vesicle-mediated transfer of CLIC1 protein is a novel mechanism for the regulation of glioblastoma growth.
    Setti M; Osti D; Richichi C; Ortensi B; Del Bene M; Fornasari L; Beznoussenko G; Mironov A; Rappa G; Cuomo A; Faretta M; Bonaldi T; Lorico A; Pelicci G
    Oncotarget; 2015 Oct; 6(31):31413-27. PubMed ID: 26429879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular vesicles derived from hypoxic glioma stem-like cells confer temozolomide resistance on glioblastoma by delivering miR-30b-3p.
    Yin J; Ge X; Shi Z; Yu C; Lu C; Wei Y; Zeng A; Wang X; Yan W; Zhang J; You Y
    Theranostics; 2021; 11(4):1763-1779. PubMed ID: 33408780
    [No Abstract]   [Full Text] [Related]  

  • 8. Comprehensive proteome profiling of glioblastoma-derived extracellular vesicles identifies markers for more aggressive disease.
    Mallawaaratchy DM; Hallal S; Russell B; Ly L; Ebrahimkhani S; Wei H; Christopherson RI; Buckland ME; Kaufman KL
    J Neurooncol; 2017 Jan; 131(2):233-244. PubMed ID: 27770278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temozolomide increases heat shock proteins in extracellular vesicles released from glioblastoma cells.
    Kıyga E; Adıgüzel Z; Önay Uçar E
    Mol Biol Rep; 2022 Sep; 49(9):8701-8713. PubMed ID: 35752701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breaking through the glioblastoma micro-environment via extracellular vesicles.
    Simon T; Jackson E; Giamas G
    Oncogene; 2020 Jun; 39(23):4477-4490. PubMed ID: 32366909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development.
    Nakano I; Garnier D; Minata M; Rak J
    Semin Cell Dev Biol; 2015 Apr; 40():17-26. PubMed ID: 25721810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tumor-Derived Extracellular Vesicles in Glioblastoma.
    Chen Y; Jin Y; Wu N
    Cells; 2021 Feb; 10(3):. PubMed ID: 33670924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles carry miR-27a-3p to promote drug resistance of glioblastoma to temozolomide by targeting BTG2.
    Chen L; Li Z; Hu S; Deng Q; Hao P; Guo S
    Cancer Chemother Pharmacol; 2022 Feb; 89(2):217-229. PubMed ID: 35039898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum-derived extracellular vesicles facilitate temozolomide resistance in glioblastoma through a HOTAIR-dependent mechanism.
    Wang X; Yu X; Xu H; Wei K; Wang S; Wang Y; Han J
    Cell Death Dis; 2022 Apr; 13(4):344. PubMed ID: 35418162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.
    Oushy S; Hellwinkel JE; Wang M; Nguyen GJ; Gunaydin D; Harland TA; Anchordoquy TJ; Graner MW
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
    Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
    Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
    Chen Z; Wei X; Shen L; Zhu H; Zheng X
    Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells.
    de Vrij J; Maas SL; Kwappenberg KM; Schnoor R; Kleijn A; Dekker L; Luider TM; de Witte LD; Litjens M; van Strien ME; Hol EM; Kroonen J; Robe PA; Lamfers ML; Schilham MW; Broekman ML
    Int J Cancer; 2015 Oct; 137(7):1630-42. PubMed ID: 25802036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics Studies on Extracellular Vesicles Derived from Glioblastoma: Where Do We Stand?
    Giuliani P; De Simone C; Febo G; Bellasame A; Tupone N; Di Virglio V; di Giuseppe F; Ciccarelli R; Di Iorio P; Angelucci S
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients.
    Sabbagh Q; André-Grégoire G; Alves-Nicolau C; Dupont A; Bidère N; Jouglar E; Guével L; Frénel JS; Gavard J
    Sci Rep; 2021 Nov; 11(1):22792. PubMed ID: 34815502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.